Current Neuropharmacology

Current Neuropharmacology

Editor-in-Chief

ISSN (Print): 1570-159X
ISSN (Online): 1875-6190

Back Subscribe
Corrigendum

Corrigendum to: Armodafinil as a Potential Pharmacological Treatment for Attention Deficit Hyperactivity Disorder in Adults: A Review

Author(s): Reyna Lamas-Aguilar, Araceli Diaz-Ruiz, Luz Navarro, Raúl Miranda-Ojeda, María de los Ángeles Martínez-Cárdenas, Alfonso Mata-Bermudez* and Camilo Rios*

Volume 23, Issue 14, 2025

Published on: 10 February, 2025

Page: [2004 - 2004] Pages: 1

DOI: 10.2174/1570159X23999250210110914

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

The author has identified an error in the department of the authors in the article titled, Armodafinil as a Potential Pharmacological Treatment for Attention Deficit Hyperactivity Disorder in Adults: A Review”, published in Current Neuropharmacology, 2024, 22(11), 1899-1908 [1].

Details of the error and a correction are provided here.

ORIGINAL

RAÚL MIRANDA-OJEDA3,4

3The Mind Project, Office for Equity, Diversity, Inclusion, and Belonging, Harvard University, Smith Campus Center, Cambridge, Massachusetts, USA;

4Faculty of Medicine, Autonomous University of Mexico State, Toluca de Lerdo, Estado de Mexico, Mexico

CORRECTED

RAÚL MIRANDA-OJEDA3,4

3Department of Physical Medicine & Rehabilitation, Harvard Medical School, Boston, Massachusetts, United States of America;

4Faculty of Medicine, Autonomous University of the State of Mexico, Av Paseo Tollocan, C. Jesu´s Carranza, Moderna de La Cruz, 50180 Toluca de Lerdo, Mexico

Publisher regret the error and apologize to readers..

The original article can be found online at: https://www.benthamscience.com/article/138216.

Erratum For:
Armodafinil as a Potential Pharmacological Treatment for Attention Deficit Hyperactivity Disorder in Adults: A Review

[1]
Lamas-Aguilar, R.; Diaz-Ruiz, A.; Navarro, L.; Miranda-Ojeda, R.; Martínez-Cárdenas, M.Á.; Mata-Bermudez, A.; Rios, C. Armodafinil as a potential pharmacological treatment for attention deficit hyperactivity disorder in adults: A review. Curr. Neuropharmacol., 2024, 22, 1899-1908.